Top Markets
Coin of the day
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Classement en actions #14767
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Prix de l'action
$16.85
Dernière synchronisation: 2023-07-07
Capitalisation boursière
$393.50M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
CH
Échange VectivBio Holding AG (VECT)

Catégorie

Historique du prix de l'action pour VectivBio Holding AG (VECT)
Prix de clôture le plus élevé : $16.72 le 2023-07-01

Prix de clôture le plus bas : $16.68 le 2021-04-01
Historique du prix de l'action de VectivBio Holding AG de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 96.64%
2022 112.95%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$745.22 4.45%
CH